跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NORDITROPIN FLEXPRO - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
NORDITROPIN FLEXPRO
Authorized
STANDARD
NORDITROPIN FLEXPRO
Novo Nordisk Canada Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e4e4d7d542b709a3
Company
Novo Nordisk Canada Inc
Type
Standard
Approval Details
Approval Id
e4e4d7d542b709a3
Drug Approval Canada Name
NORDITROPIN FLEXPRO
Product Name
NORDITROPIN FLEXPRO
Status
Marketed
Status Date
2022-12-07
Original Market Date
2022-12-07
Din
02529211
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Schedule D , Prescription
Ahfs
68:28.00
Atc Original
H01AC01 SOMATROPIN
Atc Name
h 01 ac 01
Aig Number
0131827012
Company Name
Novo Nordisk Canada Inc
Company Address
101-2476 Argentia Road, Mississauga, Ontario, Canada, L5N 6M1
Active Ingredients
SOMATROPIN
15 MG / 1.5 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e4e4d7d542b709a3
Type
Standard
Back to Health Canada Approvals